81 related articles for article (PubMed ID: 568738)
1. Bromocriptine-induced behavioral hypersensitivity: implications for the therapy of parkinsonism.
Nausieda PA; Weiner WJ; Kanapa DJ; Klawans HL
Neurology; 1978 Nov; 28(11):1183-8. PubMed ID: 568738
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic amphetamine exposure on stereotyped behavior: implications for pathogenesis of l-dopa-induced dyskinesias.
Klawans HL; Crossett P; Dana N
Adv Neurol; 1975; 9():105-12. PubMed ID: 1170714
[TBL] [Abstract][Full Text] [Related]
3. Supersensitivity to d-amphetamine- and apomorphine-induced stereotyped behavior induced by chronic d-amphetamine administration.
Klawans HL; Margolin DI; Dana N; Crosset P
J Neurol Sci; 1975 Jul; 25(3):283-9. PubMed ID: 1171935
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with bromocriptine induces behavioral supersensitivity in rats.
Hassan MN; Higgins D; Traub M; Fahn S
Life Sci; 1986 Aug; 39(6):513-8. PubMed ID: 3090394
[TBL] [Abstract][Full Text] [Related]
5. Bromocriptine holiday: effects on dopamine receptors and turning behavior in rats.
Kenny AM; Schneider MB; Baden DR; Pfeiffer RF; Murrin LC
Neurology; 1986 Mar; 36(3):400-4. PubMed ID: 3081831
[TBL] [Abstract][Full Text] [Related]
6. Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders.
Klawans HL; Margolin DI
Arch Gen Psychiatry; 1975 Jun; 32(6):725-32. PubMed ID: 1130936
[TBL] [Abstract][Full Text] [Related]
7. Behavioral effects of long-term neuroleptic treatment in Cebus monkeys.
Casey DE
Psychopharmacology Suppl; 1985; 2():211-6. PubMed ID: 3858801
[TBL] [Abstract][Full Text] [Related]
8. Bromocriptine in the treatment of parkinsonism.
Parkes JD
Drugs; 1979 May; 17(5):365-82. PubMed ID: 37066
[TBL] [Abstract][Full Text] [Related]
9. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
Johnson AM; Loew DM; Vigouret JM
Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
[TBL] [Abstract][Full Text] [Related]
10. A comparison of apomorphine, bromocriptine and Sandoz CM 29-712 (6-methyl-8a-cyanomethyl-ergoline-l) in four different turning models in the rat [proceedings].
Jaton AL; Loew DM; Vigouret JM
Br J Pharmacol; 1978 Mar; 62(3):395P. PubMed ID: 565235
[No Abstract] [Full Text] [Related]
11. Differential effects of three dopamine agonists: apomorphine, bromocriptine and lergotrile.
Silbergeld EK; Pfeiffer RF
J Neurochem; 1977 Jun; 28(6):1323-6. PubMed ID: 577501
[No Abstract] [Full Text] [Related]
12. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD
Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
[TBL] [Abstract][Full Text] [Related]
13. Behavioral effects of dopamine agonists increase with age.
Smith RC; Leelavathi DE; Lauritzen AM
Commun Psychopharmacol; 1978; 2(1):39-43. PubMed ID: 566185
[No Abstract] [Full Text] [Related]
14. Behavioral evidence for supersensitivity after chronic bromocriptine administration.
Smith RC; Strong JR; Hicks PB; Samorajski T
Psychopharmacology (Berl); 1979 Feb; 60(3):241-6. PubMed ID: 108701
[TBL] [Abstract][Full Text] [Related]
15. Postsynaptic supersensitivity and kindling: further evidence of similarities.
Flemenbaum A
Am J Drug Alcohol Abuse; 1978; 5(2):247-54. PubMed ID: 570804
[TBL] [Abstract][Full Text] [Related]
16. The effect of alpha-adrenergic receptor stimulant drugs on amphetamine or apomorphine-induced stereotypy in rats.
Zebrowska-Lupina I; Kleinrok Z; Kozyrska C; Wielosz M
Pol J Pharmacol Pharm; 1978; 30(4):459-67. PubMed ID: 33370
[TBL] [Abstract][Full Text] [Related]
17. Studies with bromocriptine: III. Concomitant administration of caffeine to patients with idiopathic parkinsonism.
Kartzinel R; Shoulson I; Calne DB
Neurology; 1976 Aug; 26(8):741-3. PubMed ID: 181692
[TBL] [Abstract][Full Text] [Related]
18. Behavioral effects of dopamine agonists across the estrous cycle in rats.
Steiner M; Katz RJ; Carroll BJ
Psychopharmacology (Berl); 1980; 71(2):147-51. PubMed ID: 6777814
[TBL] [Abstract][Full Text] [Related]
19. Behavioral facilitation following chronic administration of N-n-propylnorapomorphine.
Wilcox RE; Riffee WH; Chen PC; Hammett S; Smith RV
Psychopharmacology (Berl); 1980; 72(1):113-5. PubMed ID: 6781003
[TBL] [Abstract][Full Text] [Related]
20. Failure of apomorphine to induce dopamine receptor hypersensitivity.
Flemenbaum A
Psychopharmacology (Berl); 1979 Apr; 62(2):175-9. PubMed ID: 111281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
